On ECHEMI
Home > Drugs > Gatifloxacin Mesylate Tablets

Gatifloxacin Mesylate Tablets

Ingredients

Methylcantharidin.

Indication

For primary liver cancer.

Usage and Dosage

Oral administration. 5 to 10 tablets at a time, 3 to 4 times a day, 1 to 3 months as a course of treatment. The maximum dose is 20 to 40 tablets.

Adverse Reactions

There may be mild nausea and loss of appetite. There may also be reactions such as frequent urination, painful urination, and urgent urination.

Precautions

It is contraindicated for patients who are allergic to this product; it is contraindicated for patients with renal insufficiency.

Drug Interactions

Not yet clear.

Storage

Keep sealed.

Packaging Specification

0.2g (based on gatifloxacin)

Manufacturer

Jiangsu Lianhuan Pharmaceutical Co., Ltd.

  • Founded in:

    2000-02-22
  • Address:

    No. 9, Jiankang 1st Road, Yangzhou Bio-Health Industrial Park, Yangzhou City, Jiangsu Province
  • Tax NO.:

    91321000714094280W
  • Registered Funds:

    285.45627 million yuan
  • Website:

  • Email:

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.